Ohshima Susumu, Seyama Atsushi
Division of Morphological Science, Biomedical Research Center, Saitama Medical University, Morohongo, Moroyama, Iruma, Saitama, Japan.
Department of Pathology, International Medical Center, Saitama Medical University, Yamane, Hidaka, Saitama, Japan.
Genes Chromosomes Cancer. 2016 Jun;55(6):522-30. doi: 10.1002/gcc.22354. Epub 2016 Mar 22.
Aneuploidy is observed in the majority of human cancers and is considered to be causally related to carcinogenesis. Although malignant aneuploid cells are suggested to develop from polyploid cells formed in precancerous lesions, the mechanisms of this process remain elusive. This is partly because no experimental model is available where nontransformed polyploid human cells propagate in vitro. We previously showed that proliferative tetraploid cells can be established from normal human fibroblasts by treatment with the spindle poison demecolcine (DC). However, the limited lifespan of these cells hampered detailed analysis of a link between chromosomal instability and the oncogenic transformation of polyploid cells. Here, we report the establishment of proliferative tetraploid cells from the telomerase-immortalized normal human fibroblast cell line TIG-1. Treatment of immortalized diploid cells with DC for 4 days resulted in proliferation of cells with tetraploid DNA content and near-tetraploid/tetraploid chromosome counts. Established tetraploid cells had functional TP53 despite growing at almost the same rate as diploid cells. The frequency of clonal and sporadic chromosome aberrations in tetraploid cells was higher than in diploid cells and in one experiment, gradually increased with repeated subculture. This study suggests that tetraploid cells established from telomerase-immortalized normal human fibroblasts can be a valuable model for studying chromosomal instability and the oncogenic potential of polyploid cells. © 2016 Wiley Periodicals, Inc.
在大多数人类癌症中都观察到非整倍体现象,并且认为其与致癌作用存在因果关系。尽管有研究表明恶性非整倍体细胞是由癌前病变中形成的多倍体细胞发展而来,但这一过程的机制仍不清楚。部分原因是目前尚无实验模型可用于研究未转化的多倍体人类细胞在体外的增殖情况。我们之前的研究表明,通过纺锤体毒素秋水仙胺(DC)处理,可从正常人成纤维细胞中建立具有增殖能力的四倍体细胞。然而,这些细胞的寿命有限,阻碍了对染色体不稳定性与多倍体细胞致癌转化之间联系的详细分析。在此,我们报告了从端粒酶永生化的正常人成纤维细胞系TIG-1中建立具有增殖能力的四倍体细胞。用DC处理永生化二倍体细胞4天,可导致具有四倍体DNA含量和接近四倍体/四倍体染色体数目的细胞增殖。所建立的四倍体细胞尽管生长速率与二倍体细胞几乎相同,但具有功能性TP53。四倍体细胞中克隆性和散发性染色体畸变的频率高于二倍体细胞,并且在一项实验中,随着传代次数的增加而逐渐升高。本研究表明,从端粒酶永生化的正常人成纤维细胞中建立的四倍体细胞可成为研究染色体不稳定性和多倍体细胞致癌潜能的有价值模型。© 2016威利期刊公司。